Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xavier Rebillard
Serum Matrix Metalloproteinase-7 Is an Independent Prognostic Biomarker in Advanced Bladder Cancer
Clinical and Translational Medicine
Medicine
Molecular Medicine
Transrectal High-Intensity Focused Ultrasound in the Treatment of Localized Prostate Cancer
Journal of Endourology
Medicine
Urology
Related publications
miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer
Oncology Letters
Cancer Research
Oncology
Serum IGF-I, IGFBP-3, and Matrix Metalloproteinase-7 Levels and Acquired Chemo-Resistance in Advanced Colorectal Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Matrix Metalloproteinase Polymorphisms Are Associated With Bladder Cancer Invasiveness
Clinical Cancer Research
Cancer Research
Oncology
KIF23 Is an Independent Prognostic Biomarker in Glioma, Transcriptionally Regulated by TCF-4
Oncotarget
Oncology
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
Frontiers in Medicine
Medicine
Reply: Is Serum Matrix Metalloproteinase 9 a Useful Biomarker in Detection of Colorectal Cancer? Considering Pre-Analytical Interference That May Influence Diagnostic Accuracy
British Journal of Cancer
Cancer Research
Oncology
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
